Tara Lynn Kieffer, Chief Product Strategy Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 14,532 shares at $12.33 ($179K) on 2024-06-17, disclosed to the SEC on 2024-06-17.
Scheduled sale ($179k) by Chief Product Strategy Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.33 | 7,266 | $90K | 50.0% |
| 2 | $12.33 | 7,266 | $90K | 50.0% |
| Total | $12.33 avg | 14,532 | $179K | 100% |
| Filing → |
| ENTA | SELL | 2023-12-06 | $20K | — | Filing → |